Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes

Update Il y a 4 ans
Reference: NCT00118287

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This phase I/II trial studies how well giving azacitidine together with etanercept works in treating patients with myelodysplastic syndromes (MDS). Drugs used in chemotherapy, such as azacitidine, works in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Chemoprotective drugs, such as etanercept, may protect normal cells from the side effects of chemotherapy


Inclusion criteria

  • de Novo Myelodysplastic Syndromes,Previously Treated Myelodysplastic Syndromes,Secondary Myelodysplastic Syndromes

Links